U-Blot® Research Grade PintumomabCat. No. WA3364Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade PintumomabCat. No. WA3364
U-Blot® Research Grade PinatuzumabCat. No. WA3363
U-Blot® Research Grade PimurutamabCat. No. WA3362
U-Blot® Research Grade PimivalimabCat. No. WA3361
U-Blot® Research Grade PidilizumabCat. No. WA3360
U-Blot® Research Grade PicankibartCat. No. WA3359
U-Blot® Research Grade PF-06380101Cat. No. WA3358
U-Blot® Research Grade PexelizumabCat. No. WA3357
U-Blot® Research Grade PetosemtamabCat. No. WA3356
U-Blot® Research Grade PertuzumabCat. No. WA3355
U-Blot® Research Grade PeresolimabCat. No. WA3354
U-Blot® Research Grade PerenostobartCat. No. WA3353